Windtree Becomes First NASDAQ Firm to Add BNB to Its Balance Sheet

Windtree Therapeutics, a U.S.-listed biotech company, plans to invest in BNB, a cryptocurrency, and shares of Osprey BNB Chain Trust, using an initial $60 million investment from Build and Build Corp. The deal could potentially reach $200 million. If approved by shareholders, Windtree would become the first NASDAQ-listed company to directly hold BNB on its balance sheet. This move is seen as a way to offer U.S. investors regulated exposure to BNB and the Binance ecosystem. Following the announcement, market sentiment around BNB has increased, with observers noting it could signal the token's maturation as a reserve asset. The price of BNB is currently holding support at $690 and traders are watching the $707 level to see if BNB builds positive momentum.